- call +1-201-465-4211
- email sales@mrinsights.biz
Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).
Scope of the Report:
This report focuses on the Bacterial Conjunctivitis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.
The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.
The rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.
The worldwide market for Bacterial Conjunctivitis Drugs is expected to grow at a CAGR of roughly -3.6% over the next five years, will reach 350 million US$ in 2023, from 430 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Santen Pharmaceutical
Perrigo
Merck
Bayer
Akorn
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fluoroquinolones
Aminoglycosides
Macrolides
Others
Market Segment by Applications, can be divided into
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)
There are 15 Chapters to deeply display the global Bacterial Conjunctivitis Drugs market.
Chapter 1, to describe Bacterial Conjunctivitis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bacterial Conjunctivitis Drugs, with sales, revenue, and price of Bacterial Conjunctivitis Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bacterial Conjunctivitis Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bacterial Conjunctivitis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bacterial Conjunctivitis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bacterial Conjunctivitis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Fluoroquinolones
1.2.2 Aminoglycosides
1.2.3 Macrolides
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Infective (Viral and Bacterial)
1.3.2 Allergic
1.3.3 Irritant (Chemical)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Santen Pharmaceutical
2.1.1 Business Overview
2.1.2 Bacterial Conjunctivitis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Perrigo
2.2.1 Business Overview
2.2.2 Bacterial Conjunctivitis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Perrigo Bacterial Conjunctivitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Bacterial Conjunctivitis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Bacterial Conjunctivitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Bacterial Conjunctivitis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Bacterial Conjunctivitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Akorn
2.5.1 Business Overview
2.5.2 Bacterial Conjunctivitis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Akorn Bacterial Conjunctivitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bacterial Conjunctivitis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bacterial Conjunctivitis Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bacterial Conjunctivitis Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bacterial Conjunctivitis Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Bacterial Conjunctivitis Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bacterial Conjunctivitis Drugs Market Analysis by Regions
4.1 Global Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Bacterial Conjunctivitis Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bacterial Conjunctivitis Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
4.5 South America Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
5 North America Bacterial Conjunctivitis Drugs by Countries
5.1 North America Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Bacterial Conjunctivitis Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bacterial Conjunctivitis Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
6 Europe Bacterial Conjunctivitis Drugs by Countries
6.1 Europe Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Bacterial Conjunctivitis Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bacterial Conjunctivitis Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
6.3 UK Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
6.4 France Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bacterial Conjunctivitis Drugs by Countries
7.1 Asia-Pacific Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bacterial Conjunctivitis Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bacterial Conjunctivitis Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
7.5 India Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
8 South America Bacterial Conjunctivitis Drugs by Countries
8.1 South America Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Bacterial Conjunctivitis Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bacterial Conjunctivitis Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bacterial Conjunctivitis Drugs by Countries
9.1 Middle East and Africa Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bacterial Conjunctivitis Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bacterial Conjunctivitis Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Bacterial Conjunctivitis Drugs Sales and Growth Rate (2013-2018)
10 Global Bacterial Conjunctivitis Drugs Market Segment by Type
10.1 Global Bacterial Conjunctivitis Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bacterial Conjunctivitis Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Bacterial Conjunctivitis Drugs Revenue and Market Share by Type (2013-2018)
10.2 Fluoroquinolones Sales Growth and Price
10.2.1 Global Fluoroquinolones Sales Growth (2013-2018)
10.2.2 Global Fluoroquinolones Price (2013-2018)
10.3 Aminoglycosides Sales Growth and Price
10.3.1 Global Aminoglycosides Sales Growth (2013-2018)
10.3.2 Global Aminoglycosides Price (2013-2018)
10.4 Macrolides Sales Growth and Price
10.4.1 Global Macrolides Sales Growth (2013-2018)
10.4.2 Global Macrolides Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Bacterial Conjunctivitis Drugs Market Segment by Application
11.1 Global Bacterial Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
11.2 Infective (Viral and Bacterial) Sales Growth (2013-2018)
11.3 Allergic Sales Growth (2013-2018)
11.4 Irritant (Chemical) Sales Growth (2013-2018)
12 Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.1 Global Bacterial Conjunctivitis Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Bacterial Conjunctivitis Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.2.2 Europe Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.2.4 South America Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bacterial Conjunctivitis Drugs Market Forecast (2018-2023)
12.3 Bacterial Conjunctivitis Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Bacterial Conjunctivitis Drugs Market Share Forecast by Type (2018-2023)
12.4 Bacterial Conjunctivitis Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Bacterial Conjunctivitis Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bacterial Conjunctivitis Drugs Picture
Table Product Specifications of Bacterial Conjunctivitis Drugs
Figure Global Sales Market Share of Bacterial Conjunctivitis Dr
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
